NIH Marketplace Update
International Mail Prescriptions: CBP Delays Rule to January 20
High-Cost Rx Insights for Benefits Professionals
What the Entry Type 13 extension means for employer health plans that use international Rx sourcing
By Jake Velie, CPT
Founder, Chairman & CEO, National Integrative Health
Download the Full Report (PDF)
Read the full update online or save a copy — no form required.
What You'll Learn
Inside this update
AT A GLANCE
The old date, the new mandatory date of January 20, 2027, what Entry Type 13 covers, why drugs are affected, and what it does not cover.
QUESTIONS PLAN SPONSORS SHOULD BE ASKING NOW
Six practical questions on vendor continuity, member impact, transition planning, stop-loss, and whether your plan relies on a single lever.
SOURCING IS ONE TACTIC, NOT THE FULL STRATEGY
Clinical review, plan design guardrails, site-of-care optimization, claims data analysis, procurement options, and stop-loss coordination.
Developed for the stakeholders responsible for plan spend
For plan sponsors, benefits professionals, brokers, TPAs, and stop-loss partners. Educational content; not legal or clinical advice.
Have Questions About the Marketplace?
Discover how National Integrative Health can help your organization navigate evolving healthcare and pharmacy challenges. Connect with our team to learn more.